Search Results - "Weikel, Dianna"

Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines by Hong, Catherine H. L., Gueiros, Luiz Alcino, Fulton, Janet S., Cheng, Karis Kin Fong, Kandwal, Abhishek, Galiti, Dimitra, Fall-Dickson, Jane M., Johansen, Jorgen, Ameringer, Suzanne, Kataoka, Tomoko, Weikel, Dianna, Eilers, June, Ranna, Vinasha, Vaddi, Anusha, Lalla, Rajesh V., Bossi, Paolo, Elad, Sharon

“…Purpose The aim of this study was to update the clinical practice guidelines for the use of basic oral care (BOC) interventions for the prevention and/or…”
Get full text

Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy by Peterson, Douglas E., Öhrn, Kerstin, Bowen, Joanne, Fliedner, Monica, Lees, Judith, Loprinzi, Charles, Mori, Takehiko, Osaguona, Anthony, Weikel, Dianna S., Elad, Sharon, Lalla, Rajesh V.

“…Purpose This systematic review analyzed the strength of the literature and defined clinical practice guidelines for the use of oral cryotherapy for the…”
Get full text

Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical Features and Risk Factors by BADROS, Ashraf, WEIKEL, Dianna, MEILLER, Timothy, SALAMA, Andrew, GOLOUBEVA, Olga, SCHNEIDER, Abraham, RAPOPORT, Aaron, FENTON, Robert, GAHRES, Natalie, SAUSVILLE, Edward, ORD, Robert

“…To describe the clinical, radiologic, and pathologic features and risk factors for osteonecrosis of the jaw (ONJ) in multiple myeloma (MM) patients. A…”
Get full text

456 Analysis of Clinical, Histologic, and Molecular Characteristics of Proliferative Verrucous Leukoplakia by Weikel, Dana R., Isaacs, Anne, Basile, John, Weikel, Dianna S., Meiller, Timothy F.

“…OBJECTIVES/GOALS: This study aims to develop objectively scored histological characteristics of early oral leukoplakia, which may be correlated with molecular…”
Get full text

Prospective Observational Study of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma: Microbiota Profiling and Cytokine Expression by Badros, Ashraf Z, Meddeb, Mariam, Weikel, Dianna, Philip, Sunita, Milliron, Todd, Lapidus, Rena, Hester, Lisa, Goloubeva, Olga, Meiller, Timothy F, Mongodin, Emmanuel F

“…Define incidence and risk factors of osteonecrosis of the jaw (ONJ) and explore oral microbial signatures and host immune response as reflected by cytokine…”
Get full text

A novel bioassay model to determine clinically significant bisphosphonate levels by Scheper, Mark A., Badros, Ashraf, Salama, Andrew R., Warburton, Gary, Cullen, Kevin J., Weikel, Dianna S., Meiller, Timothy F.

“…Purpose Bisphosphonate-associated osteonecrosis (BON) is a recently recognized oral complication of bisphosphonate (BP) therapy. Currently, research into the…”
Get full text

Recognition and Management of Oral Mucosal Injury Caused by Mammalian Target of Rapamycin Inhibitors: A Case Series by Meiller, Timothy F., Varlotta, Sharon, Weikel, Dianna

“…The mammalian target of rapamycin inhibitors (mTORIs) everolimus and temsirolimus are approved by the US Food and Drug Administration (FDA) for the treatment…”
Get full text

The care and management of bisphosphonate--associated osteonecrosis of the jaw in the patient with multiple myeloma: a case study by Teah, Melvin J, Syme, Sheryl L Ernest, Scheper, Mark, Weikel, Dianna S

“…This is a case study of a patient with multiple myeloma presenting with bisphosphonate-associated osteonecrosis of the jaw after an extraction of tooth #18…”
Get more information

A novel bioassay model to determine clinically significant bisphosphonate levels by Scheper, Mark A., Badros, Ashraf, Salama, Andrew R., Warburton, Gary, Cullen, Kevin J., Weikel, Dianna S., Meiller, Timothy F.

Get full text

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy by Lalla, Rajesh V., Bowen, Joanne, Barasch, Andrei, Elting, Linda, Epstein, Joel, Keefe, Dorothy M., McGuire, Deborah B., Migliorati, Cesar, Nicolatou‐Galitis, Ourania, Peterson, Douglas E., Raber‐Durlacher, Judith E., Sonis, Stephen T., Elad, Sharon

“…BACKGROUND Mucositis is a highly significant, and sometimes dose‐limiting, toxicity of cancer therapy. The goal of this systematic review was to update the…”
Get full text

Salivary biomarker profiles in E‐cigarette users and conventional smokers: A cross‐sectional study by Faridoun, Afnan, Sultan, Ahmed S., Jabra‐Rizk, Mary Ann, Weikel, Dianna, Varlotta, Sharon, Meiller, Timothy F.

Get full text

Pharmacotherapy for breast cancer: a short primer for the dentist by Wynn, Richard L, Weikel, Dianna S, Tait, Nancy, Meiller, Timothy F

Get more information

Prospective Observational Study of 110 Multiple Myeloma (MM) Patients On Monthly Versus 3 Monthly Infusion of Zoledronic Acid by Badros, Ashraf Z., Philip, Sunita, Lesho, Patricia, Weikel, Dianna, Goloubeva, Olga, Sadowska, Mariola, Lapidus, Rena, Hester, Lisa, Milliron, Todd, Meiller, Timothy

“…Abstract 4245 Osteonecrosis of the jaw (ONJ) is a recognized risk of bisphosphonate infusion; the incidence, etiology, risk factors and pathophysiology remains…”
Get full text

Cytokine Alteration In Multiple Myeloma (MM) Patients and Bisphosphonate (BP)-Related Osteonecrosis Of The Jaw (BRONJ) by Badros, Ashraf, Philip, Sunita, Lesho, Patricia, Sadowska, Mariola, Weikel, Dianna, Meiller, Timothy, Lapidus, Rena, Hester, Lisa, Milliron, Todd, Goloubeva, Olga

“…BRONJ is a complex process that involves interplay of drug effect, bacteria-host immune interactions, and alteration of cytokines and inflammatory mediators…”
Get full text

Preexisting Oral Disease as a Risk Factor in Oral Complications during PBSCT in Multiple Myeloma Patients by Meiller, Timothy F, Scheper, Mark A, Weikel, Dianna, Jabra-Rizk, Mary Ann, Badros, Ashraf Z.

“…Oral complications have the potential to significantly increase patient morbidity when they occur during myelosuppressive chemotherapy. In a present cohort of…”
Get full text

Interruption of Bisphosphonates (BP) Therapy in Multiple Myeloma (MM) Patients and Osteonecrosis of the Jaw (ONJ) by Badros, Ashraf, Goloubeva, Olga, Weikel, Dianna, Rapoport, Aaron P., Akpek, Gorgun, Yanovich, Saul, Meiller, Timothy, Sausville, Edward

“…ONJ is a serious complication in MM patients; incidence is time-dependent with highest risk seen after long-term use of BP in older MM patients, often after…”
Get full text

Incidence of fever following invasive oral interventions in the myelosuppressed cancer patient by Weikel, D S, Peterson, D E, Rubinstein, L E, Metzger-Samuels, C, Overholser, Jr, C D

“…Oral complications in cancer patients with chemotherapy-induced myelosuppression contribute to morbidity and mortality. However, guidelines for oral care to…”
Get more information

Periodontal disease and oral microbial successions during myelosuppressive cancer chemotherapy by Reynolds, M A, Minah, G E, Peterson, D E, Weikel, D S, Williams, L T, Overholser, C D, DePaola, L G, Suzuki, J B

“…Factors contributing to the succession of opportunistic pathogens at oral sites, including the periodontium, during myelosuppressive chemotherapy are poorly…”
Get more information

Recognition and Management of Oral Mucosal Injury Caused by Mammalian Target of Rapamycin Inhibitors: A Case Series by Meiller, Timothy F, Varlotta, Sharon, Weikel, Dianna

Get full text

Effect of granulocytopenia on oral microbial relationships in patients with acute leukemia by Peterson, D E, Minah, G E, Reynolds, M A, Weikel, D S, Overholser, C D, DePaola, L G, Wade, J C, Suzuki, J B

“…Risk for acute infection increases as granulocyte levels decrease secondary to myelosuppressive chemotherapy in patients with acute nonlymphocytic leukemia…”
Get more information